150 related articles for article (PubMed ID: 9811164)
21. Mechanisms of glucose transport at the blood-brain barrier: an in vitro study.
McAllister MS; Krizanac-Bengez L; Macchia F; Naftalin RJ; Pedley KC; Mayberg MR; Marroni M; Leaman S; Stanness KA; Janigro D
Brain Res; 2001 Jun; 904(1):20-30. PubMed ID: 11516408
[TBL] [Abstract][Full Text] [Related]
22. Choline uptake by mouse brain capillary endothelial cells in culture.
Sawada N; Takanaga H; Matsuo H; Naito M; Tsuruo T; Sawada Y
J Pharm Pharmacol; 1999 Jul; 51(7):847-52. PubMed ID: 10467961
[TBL] [Abstract][Full Text] [Related]
23. Transport mechanism of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors at the blood-brain barrier.
Tsuji A; Saheki A; Tamai I; Terasaki T
J Pharmacol Exp Ther; 1993 Dec; 267(3):1085-90. PubMed ID: 8263769
[TBL] [Abstract][Full Text] [Related]
24. In vivo evidence for the efflux transport of pentazocine from the brain across the blood-brain barrier using the brain efflux index method.
Moriki Y; Suzuki T; Furuishi T; Fukami T; Tomono K; Watanabe J
J Drug Target; 2005 Jan; 13(1):53-9. PubMed ID: 15848954
[TBL] [Abstract][Full Text] [Related]
25. Efflux of taurocholic acid across the blood-brain barrier: interaction with cyclic peptides.
Kitazawa T; Terasaki T; Suzuki H; Kakee A; Sugiyama Y
J Pharmacol Exp Ther; 1998 Aug; 286(2):890-5. PubMed ID: 9694947
[TBL] [Abstract][Full Text] [Related]
26. Functional characterization of mouse organic anion transporting peptide 1a4 in the uptake and efflux of drugs across the blood-brain barrier.
Ose A; Kusuhara H; Endo C; Tohyama K; Miyajima M; Kitamura S; Sugiyama Y
Drug Metab Dispos; 2010 Jan; 38(1):168-76. PubMed ID: 19833843
[TBL] [Abstract][Full Text] [Related]
27. Involvement of P-glycoprotein in blood-brain barrier transport of pentazocine in rats using brain uptake index method.
Moriki Y; Suzuki T; Fukami T; Hanano M; Tomono K; Watanabe J
Biol Pharm Bull; 2004 Jun; 27(6):932-5. PubMed ID: 15187451
[TBL] [Abstract][Full Text] [Related]
28. Involvement of organic anion transporters in the efflux of uremic toxins across the blood-brain barrier.
Deguchi T; Isozaki K; Yousuke K; Terasaki T; Otagiri M
J Neurochem; 2006 Feb; 96(4):1051-9. PubMed ID: 16445853
[TBL] [Abstract][Full Text] [Related]
29. Brain to blood efflux transport of adenosine: blood-brain barrier studies in the rat.
Isakovic AJ; Abbott NJ; Redzic ZB
J Neurochem; 2004 Jul; 90(2):272-86. PubMed ID: 15228584
[TBL] [Abstract][Full Text] [Related]
30. ATA2 is predominantly expressed as system A at the blood-brain barrier and acts as brain-to-blood efflux transport for L-proline.
Takanaga H; Tokuda N; Ohtsuki S; Hosoya K; Terasaki T
Mol Pharmacol; 2002 Jun; 61(6):1289-96. PubMed ID: 12021389
[TBL] [Abstract][Full Text] [Related]
31. Contribution of organic anion transporter 3 (Slc22a8) to the elimination of p-aminohippuric acid and benzylpenicillin across the blood-brain barrier.
Kikuchi R; Kusuhara H; Sugiyama D; Sugiyama Y
J Pharmacol Exp Ther; 2003 Jul; 306(1):51-8. PubMed ID: 12684544
[TBL] [Abstract][Full Text] [Related]
32. In vitro and in vivo transport of zidovudine (AZT) across the blood-brain barrier and the effect of transport inhibitors.
Masereeuw R; Jaehde U; Langemeijer MW; de Boer AG; Breimer DD
Pharm Res; 1994 Feb; 11(2):324-30. PubMed ID: 8165196
[TBL] [Abstract][Full Text] [Related]
33. Role of blood-brain barrier organic anion transporter 3 (OAT3) in the efflux of indoxyl sulfate, a uremic toxin: its involvement in neurotransmitter metabolite clearance from the brain.
Ohtsuki S; Asaba H; Takanaga H; Deguchi T; Hosoya K; Otagiri M; Terasaki T
J Neurochem; 2002 Oct; 83(1):57-66. PubMed ID: 12358729
[TBL] [Abstract][Full Text] [Related]
34. Blood-brain barrier transport of naloxone does not involve P-glycoprotein-mediated efflux.
Suzuki T; Miyata M; Zaima C; Furuishi T; Fukami T; Kugawa F; Tomono K
J Pharm Sci; 2010 Jan; 99(1):413-21. PubMed ID: 19530072
[TBL] [Abstract][Full Text] [Related]
35. Human immunodeficiency virus type 1 transport across the in vitro mouse brain endothelial cell monolayer.
Nakaoke R; Ryerse JS; Niwa M; Banks WA
Exp Neurol; 2005 May; 193(1):101-9. PubMed ID: 15817268
[TBL] [Abstract][Full Text] [Related]
36. Blood-brain barrier produces significant efflux of L-aspartic acid but not D-aspartic acid: in vivo evidence using the brain efflux index method.
Hosoya K; Sugawara M; Asaba H; Terasaki T
J Neurochem; 1999 Sep; 73(3):1206-11. PubMed ID: 10461913
[TBL] [Abstract][Full Text] [Related]
37. Characterization of the L-glutamate clearance pathways across the blood-brain barrier and the effect of astrocytes in an in vitro blood-brain barrier model.
Helms HC; Aldana BI; Groth S; Jensen MM; Waagepetersen HS; Nielsen CU; Brodin B
J Cereb Blood Flow Metab; 2017 Dec; 37(12):3744-3758. PubMed ID: 28145808
[TBL] [Abstract][Full Text] [Related]
38. Limited distribution of new quinolone antibacterial agents into brain caused by multiple efflux transporters at the blood-brain barrier.
Tamai I; Yamashita J; Kido Y; Ohnari A; Sai Y; Shima Y; Naruhashi K; Koizumi S; Tsuji A
J Pharmacol Exp Ther; 2000 Oct; 295(1):146-52. PubMed ID: 10991972
[TBL] [Abstract][Full Text] [Related]
39. Rat organic anion transporter 3 (rOAT3) is responsible for brain-to-blood efflux of homovanillic acid at the abluminal membrane of brain capillary endothelial cells.
Mori S; Takanaga H; Ohtsuki S; Deguchi T; Kang YS; Hosoya K; Terasaki T
J Cereb Blood Flow Metab; 2003 Apr; 23(4):432-40. PubMed ID: 12679720
[TBL] [Abstract][Full Text] [Related]
40. Study on brain interstitial fluid distribution and blood-brain barrier transport of baclofen in rats by microdialysis.
Deguchi Y; Inabe K; Tomiyasu K; Nozawa K; Yamada S; Kimura R
Pharm Res; 1995 Dec; 12(12):1838-44. PubMed ID: 8786954
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
